Therapeutic Asset Ratings

17,289 results matching 1 filter

91,583 assets · 7,906 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
ETOPOSIDE T-Cell Childhood Acute Lymphocytic Leukemia	National Cancer Institute (NCI)	P3	BB (70)
Fludarabine Acute Megakaryoblastic Leukemia	Fred Hutchinson Cancer Center	P3	BB (70)
Fludarabine Acute Erythroid Leukemia	Fred Hutchinson Cancer Center	P3	BB (70)
Fludarabine Chronic Myeloid Leukemia	Ohio State University Comprehensive Cancer Center	P3	BB (70)
FLUOROURACILUM Anal Carcinoma	Federation Francophone de Cancerologie Digestive	P3	BB (70)
FLUOROURACILUM Gastroesophageal Junction Adenocarcinoma	Alliance for Clinical Trials in Oncology	P3	BB (70)
FLUOROURACILUM Metastatic Malignant Neoplasm	I-Mab Biopharma US Limited	P3	BB (70)
Fulzerasib Non-Small Cell Lung Carcinoma	Shandong Suncadia Medicine Co., Ltd.	P3	BB (70)
Giredestrant Estrogen-Receptor Positive Breast Cancer	Hoffmann-La Roche	P3	BB (70)
Glecirasib Non-Small Cell Lung Carcinoma	Shandong Suncadia Medicine Co., Ltd.	P3	BB (70)
Idarubicin Childhood Acute Myeloid Leukemia	Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University	P3	BB (70)
Idarubicin Leukemia	Affiliated Hospital of Nantong University	P3	BB (70)
Idarubicin Myelodysplastic Syndrome With Excess Blasts	Fred Hutchinson Cancer Center	P3	BB (70)
Irinotecan Adult Glioblastoma	NaviFUS Corporation	P3	BB (70)
Irinotecan Digestive System Neuroendocrine Tumor, Grade 1/2	National Cancer Institute (NCI)	P3	BB (70)
Irinotecan Ovarian Disorder	Xiaoxiang Chen	P3	BB (70)
Irinotecan Breast Carcinoma	OHSU Knight Cancer Institute	P3	BB (70)
Letrozole Ovarian Serous Adenocarcinoma	Memorial Sloan Kettering Cancer Center	P3	BB (70)
Linerixibat Cholestasis	GlaxoSmithKline	P3	BB (70)
MELPHALAN Disease Related To Hematopoietic Stem Cell Transplant	Institute of Hematology & Blood Diseases Hospital, China	P3	BB (70)
MERCAPTOPURINE ANHYDROUS Leukemia	Dana-Farber Cancer Institute	P3	BB (70)
METHOTREXATE Acute Undifferentiated Leukemia	Therapeutic Advances in Childhood Leukemia Consortium	P3	BB (70)
METHOTREXATE Disease Related To Hematopoietic Stem Cell Transplant	Oncoimmune, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)	P3	BB (70)
METHOTREXATE B-Lymphoblastic Leukemia/Lymphoma With T(9;22)(Q34.1;Q11.2)	Novartis Pharmaceuticals	P3	BB (70)
METHOTREXATE Childhood Myelodysplastic Syndrome	Children's Oncology Group	P3	BB (70)

Showing 1101 to 1125 of 17,289 assets

PreviousPage 45 of 692Next